The references for supplementary table 2 and 3
Diagnosis
MicroRNA names
miR-16[1]
miR-17[2]
miR-18a[3]
miR-21[4]
miR-21[5]
miR-21[6]
miR-21[7]
miR-21[8]
miR-21[9]
miR-25[1]
miR-92a[1]
miR-106a[2]
miR-106b[7]
miR-151-5p[10]
miR-187[11]
miR-191[12]
miR-199a-3p[10]
miR-200c[13]
miR-218[5]
miR-223[5]
miR-370[14]
miR-371-5p[11]
miR-375[15]
miR-378[11]
miR-421[16]
miR-451[1]
miR-451[17]
miR-486-5p[1]
miR-486-5p[17]
piR-651[18]
piR-823[18]
H19[19]
LINC0015[20]
Prognosis
MicroRNA names
miR-15a[21]
miR-16[21]
miR-17-5p[22]
miR-17-5p[23]
miR-20a[21]
miR-20a[22]
miR-20b[21]
miR-20b[24]
miR-21[21,29]
miR-21[25,29]
miR-21[26,29]
miR-21[27,29]
miR-21[28,29]
miR-22[30]
miR-26a[31]
miR-34a[21]
miR-103[21]
miR-106a[21]
miR-106b[21]
miR-107[21]
miR-107[32]
miR-122[33]
miR-125a-3p[34]
miR-125a-5p[35]
miR-132[36]
miR-143[21]
miR-143[37]
miR-144[38]
miR-146[37]
miR-148a[40]
miR-150[24]
miR-185[21]
miR-192[33]
miR-200a[21]
miR-200c[13]
miR-204[41]
miR-206[42]
miR-214[43]
miR-425[21]
miR-222[44]
miR-630[45]
let7i[46]
H19[47]
GAS5[48]
ANRIL[49]
HOTAIR[50]
HOTAIR[51]
LET[52]
FENDRR[53]
CCAT2[54]
table 2
[1] C. Zhu, C. Ren, J. Han, Y. Ding, J. Du, N. Dai, J. Dai, H. Ma, Z. Hu, H. Shen, Y.
Xu, G. Jin, A five-microRNA panel in plasma was identified as potential biomarker
for early detection of gastric cancer, British journal of cancer, 110 (2014) 2291-2299.
[2] H. Zhou, J.M. Guo, Y.R. Lou, X.J. Zhang, F.D. Zhong, Z. Jiang, J. Cheng, B.X.
Xiao, Detection of circulating tumor cells in peripheral blood from patients with
gastric cancer using microRNA as a marker, Journal of molecular medicine, 88 (2010)
709-717.
[3] M. Tsujiura, S. Komatsu, D. Ichikawa, A. Shiozaki, H. Konishi, H. Takeshita, R.
Moriumura, H. Nagata, T. Kawaguchi, S. Hirajima, T. Arita, H. Fujiwara, K. Okamoto,
E. Otsuji, Circulating miR-18a in plasma contributes to cancer detection and
monitoring in patients with gastric cancer, Gastric cancer : official journal of the
International Gastric Cancer Association and the Japanese Gastric Cancer Association,
(2014).
[4] B. Wang, Q. Zhang, The expression and clinical significance of circulating
microRNA-21 in serum of five solid tumors, Journal of cancer research and clinical
oncology, 138 (2012) 1659-1666.
[5] B.S. Li, Y.L. Zhao, G. Guo, W. Li, E.D. Zhu, X. Luo, X.H. Mao, Q.M. Zou, P.W.
Yu, Q.F. Zuo, N. Li, B. Tang, K.Y. Liu, B. Xiao, Plasma microRNAs, miR-223,
miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection, PloS
one, 7 (2012) e41629.
[6] Y. Zheng, L. Cui, W. Sun, H. Zhou, X. Yuan, M. Huo, J. Chen, Y. Lou, J. Guo,
MicroRNA-21 is a new marker of circulating tumor cells in gastric cancer patients,
Cancer biomarkers : section A of Disease markers, 10 (2011) 71-77.
[7] A. Shiotani, T. Murao, Y. Kimura, H. Matsumoto, T. Kamada, H. Kusunoki, K.
Inoue, N. Uedo, H. Iishi, K. Haruma, Identification of serum miRNAs as novel
non-invasive biomarkers for detection of high risk for early gastric cancer, British
journal of cancer, 109 (2013) 2323-2330.
[8]M. Tsujiura, D. Ichikawa, S. Komatsu, A. Shiozaki, H. Takeshita, Circulating
microRNAs in plasma of patients with gastric cancers, Br J Cancer, 102(2010)
1174–1179.
[9]J. Shen, C. Feng, B. Hao, L. Mei, Application of miR-21 and let-7a in serumfor
non-invasive diagnosis of gastric cancer and evaluation of surgery results, Journal of
Zhengzhou University, 47(2012) 722–725.
[10]C. Li, J.F. Li, Q. Cai, Q.Q. Qiu, M. Yan, B.Y. Liu, Z.G. Zhu, miRNA-199a-3p in
plasma as a potential diagnostic biomarker for gastric cancer, Annals of surgical
oncology, 20 Suppl 3 (2013) S397-405.
[11] H. Liu, L. Zhu, B. Liu, L. Yang, X. Meng, W. Zhang, Y. Ma, H. Xiao,
Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early
detection of gastric cancer, Cancer letters, 316 (2012) 196-203.
[12] W.Z. Peng, R. Ma, F. Wang, J. Yu, Z.B. Liu, Role of miR-191/425 cluster in
tumorigenesis and diagnosis of gastric cancer, International journal of molecular
sciences, 15 (2014) 4031-4048.
[13] M. Valladares-Ayerbes, M. Reboredo, V. Medina-Villaamil, P. Iglesias-Diaz, M.J.
Lorenzo-Patino, M. Haz, I. Santamarina, M. Blanco, J. Fernandez-Tajes, M. Quindos,
A. Carral, A. Figueroa, L.M. Anton-Aparicio, L. Calvo, Circulating miR-200c as a
diagnostic and prognostic biomarker for gastric cancer, Journal of translational
medicine, 10 (2012) 186.
[14] S.S. Lo, P.S. Hung, J.H. Chen, H.F. Tu, W.L. Fang, C.Y. Chen, W.T. Chen, N.R.
Gong, C.W. Wu, Overexpression of miR-370 and downregulation of its novel target
TGFbeta-RII contribute to the progression of gastric carcinoma, Oncogene, 31 (2012)
226-237.
[15] W.-H. Zhang, J.-H. Gui, C.-Z. Wang, Q. Chang, S.-P. Xu, C.-H. Cai, Y.-N. Li,
Y.-P. Tian, L. Yan, B. Wu, The Identification of miR-375 as a Potential Biomarker in
Distal Gastric Adenocarcinoma, Oncology Research Featuring Preclinical and
Clinical Cancer Therapeutics, 20 (2012) 139-147.
[16] H. Zhou, B. Xiao, F. Zhou, H. Deng, X. Zhang, Y. Lou, Z. Gong, C. Du, J. Guo,
MiR-421 is a functional marker of circulating tumor cells in gastric cancer patients,
Biomarkers : biochemical indicators of exposure, response, and susceptibility to
chemicals, 17 (2012) 104-110.
[17] H. Konishi, D. Ichikawa, S. Komatsu, A. Shiozaki, M. Tsujiura, H. Takeshita, R.
Morimura, H. Nagata, T. Arita, T. Kawaguchi, S. Hirashima, H. Fujiwara, K.
Okamoto, E. Otsuji, Detection of gastric cancer-associated microRNAs on microRNA
microarray comparing pre- and post-operative plasma, British journal of cancer, 106
(2012) 740-747.
[18] L. Cui, Y. Lou, X. Zhang, H. Zhou, H. Deng, H. Song, X. Yu, B. Xiao, W. Wang,
J. Guo, Detection of circulating tumor cells in peripheral blood from patients with
gastric cancer using piRNAs as markers, Clinical biochemistry, 44 (2011) 1050-1057.
[19] T. Arita, D. Ichikawa, H. Konishi, S. Komatsu, A. Shiozaki, K. Shoda, T.
Kawaguchi, S. Hirajima, H. Nagata, T. Kubota, H. Fujiwara, K. Okamoto, E. Otsuji,
Circulating long non-coding RNAs in plasma of patients with gastric cancer,
Anticancer research, 33 (2013) 3185-3193.
[20] Q. Li, Y. Shao, X. Zhang, T. Zheng, M. Miao, L. Qin, B. Wang, G. Ye, B. Xiao, J.
Guo, Plasma long noncoding RNA protected by exosomes as a potential stable
biomarker for gastric cancer. Tumour biology : the journal of the International Society
for Oncodevelopmental Biology and Medicine (2014).
[21] S. Osawa, Y. Shimada, S. Sekine, T. Okumura, T. Nagata, J. Fukuoka, K. Tsukada,
MicroRNA profiling of gastric cancer patients from formalin-fixed paraffin-embedded
samples, Oncology letters, 2 (2011) 613-619.
[22] M. Wang, H. Gu, S. Wang, H. Qian, W. Zhu, L. Zhang, C. Zhao, Y. Tao, W. Xu,
Circulating miR-17-5p and miR-20a: molecular markers for gastric cancer, Molecular
medicine reports, 5 (2012) 1514-1520.
[23] Q. Wu, G. Luo, Z. Yang, F. Zhu, Y. An, Y. Shi, D. Fan, miR-17-5p promotes
proliferation by targeting SOCS6 in gastric cancer cells, FEBS letters, 588 (2014)
2055-2062.
[24] Ishiguro, microRNA expression profile in undifferentiated gastric cancer,
International journal of oncology, (1992).
[25] S. Komatsu, D. Ichikawa, M. Tsujiura, H. Konishi, H. Takeshita, H. Nagata, T.
Kawaguchi, S. Hirajima, T. Arita, A. Shiozaki, T. Kubota, H. Fujiwara, K. Okamoto,
E. Otsuji, Prognostic impact of circulating miR-21 in the plasma of patients with
gastric carcinoma, Anticancer research, 33 (2013) 271-276.
[26] J. Song, Z. Bai, J. Zhang, H. Meng, J. Cai, W. Deng, J. Bi, X. Ma, Z. Zhang,
Serum microRNA-21 levelsare related to tumor size in gastric cancer patients but
cannot predict prognosis. Oncology letters 6 (2013) 1733-1737.
[27]J. Jiang, X. Zheng, X. Xu, Q. Zhou, H. Yan, X. Zhang, B. Lu, C. Wu, J. Ju,
Prognostic significance of miR-181b and miR-21 in gastric cancer patients treated
with S-1/Oxaliplatin or Doxifluridine/Oxaliplatin. PloS one 6 (2011) e23271.
[28]Y. Xu, J. Sun, J. Xu, Q. Li, Y. Guo, Q. Zhang, miR-21 Is a Promising Novel
Biomarker for Lymph Node Metastasis in Patients with Gastric Cancer,
Gastroenterology research and practice, 2012 (2012) 640168.
[29]Z. Wang, Q. Cai, Z. Jiang, B. Liu, Z. Zhu, C. Li, Prognostic role of MicroRNA-21
in gastric cancer: a meta-analysis. Medical science monitor : international medical
journal of experimental and clinical research 20 (2014) 1668-1674.
[30] W. Wang, F. Li, Y. Zhang, Y. Tu, Q. Yang, X. Gao, Reduced expression of
miR-22 in gastric cancer is related to clinicopathologic characteristics or patient
prognosis, Diagnostic pathology, 8 (2013) 102.
[31]M. Deng, H.L. Tang, X.H. Lu, M.Y. Liu, X.M. Lu, Y.X. Gu, J.F. Liu, Z.M. He,
miR-26a suppresses tumor growth and metastasis by targeting FGF9 in gastric cancer,
PloS one, 8 (2013) e72662.
[32]T. Inoue, H. Iinuma, E. Ogawa, T. Inaba, R. Fukushima, Clinicopathological and
prognostic significance of microRNA-107 and its relationship to DICER1 mRNA
expression in gastric cancer, Oncology reports, 27 (2012) 1759-1764.
[33]Q. Chen, X. Ge, Y. Zhang, H. Xia, D. Yuan, Q. Tang, L. Chen, X. Pang, W. Leng,
F. Bi, Plasma miR-122 and miR-192 as potential novel biomarkers for the early
detection of distant metastasis of gastric cancer, Oncology reports, 31 (2014)
1863-1870.
[34]Y. Hashiguchi, N. Nishida, K. Mimori, T. Sudo, F. Tanaka, K. Shibata, H. Ishii, H.
Mochizuki, K. Hase, Y. Doki, M. Mori, Down-regulation of miR-125a-3p in human
gastric cancer and its clinicopathological significance, International journal of
oncology, 40 (2012) 1477-1482.
[35] N. Nishida, K. Mimori, M. Fabbri, T. Yokobori, T. Sudo, F. Tanaka, K. Shibata, H.
Ishii, Y. Doki, M. Mori, MicroRNA-125a-5p is an independent prognostic factor in
gastric cancer and inhibits the proliferation of human gastric cancer cells in
combination with trastuzumab, Clinical cancer research : an official journal of the
American Association for Cancer Research, 17 (2011) 2725-2733.
[36] X. Liu, H. Yu, H. Cai, Y. Wang, The expression and clinical significance of
miR-132 in gastric cancer patients, Diagnostic pathology, 9 (2014) 57.
[37] Y. Naito, N. Sakamoto, N. Oue, M. Yashiro, K. Sentani, K. Yanagihara, K.
Hirakawa, W. Yasui, MicroRNA-143 regulates collagen type III expression in stromal
fibroblasts of scirrhous type gastric cancer, Cancer science, 105 (2014) 228-235.
[38] S. Akiyoshi, T. Fukagawa, H. Ueo, M. Ishibashi, Y. Takahashi, M. Fabbri, M.
Sasako, Y. Maehara, K. Mimori, M. Mori, Clinical significance of miR-144-ZFX axis
in disseminated tumour cells in bone marrow in gastric cancer cases, British journal of
cancer, 107 (2012) 1345-1353.
[39] R. Kogo, K. Mimori, F. Tanaka, S. Komune, M. Mori, Clinical significance of
miR-146a in gastric cancer cases, Clinical cancer research : an official journal of the
American Association for Cancer Research, 17 (2011) 4277-4284.
[40] N. Sakamoto, Y. Naito, N. Oue, K. Sentani, N. Uraoka, H. Zarni Oo, K.
Yanagihara, K. Aoyagi, H. Sasaki, W. Yasui, MicroRNA-148a is downregulated in
gastric cancer, targets MMP7, and indicates tumor invasiveness and poor prognosis,
Cancer science, 105 (2014) 236-243.
[41] A. Sacconi, F. Biagioni, V. Canu, F. Mori, A. Di Benedetto, L. Lorenzon, C.
Ercolani, S. Di Agostino, A.M. Cambria, S. Germoni, G. Grasso, R. Blandino, V.
Panebianco, V. Ziparo, O. Federici, P. Muti, S. Strano, F. Carboni, M. Mottolese, M.
Diodoro, E. Pescarmona, A. Garofalo, G. Blandino, miR-204 targets Bcl-2 expression
and enhances responsiveness of gastric cancer, Cell death & disease, 3 (2012) e423.
[42] Q. Yang, C. Zhang, B. Huang, H. Li, R. Zhang, Y. Huang, J. Wang,
Downregulation of microRNA-206 is a potent prognostic marker for patients with
gastric cancer, European journal of gastroenterology & hepatology, 25 (2013)
953-957.
[43]Y.W. Wang, D.B. Shi, X. Chen, C. Gao, P. Gao, Clinicopathological significance
of microRNA-214 in gastric cancer and its effect on cell biological behaviour, PloS
one, 9 (2014) e91307.
[44]B.H. Kim, S.W. Hong, A. Kim, S.H. Choi, S.O. Yoon, Prognostic implications for
high expression of oncogenic microRNAs in advanced gastric carcinoma, Journal of
surgical oncology, 107 (2013) 505-510.
[45] D. Chu, Z. Zhao, Y. Li, J. Li, J. Zheng, W. Wang, Q. Zhao, G. Ji, Increased
microRNA-630 expression in gastric cancer is associated with poor overall survival,
PloS one, 9 (2014) e90526.
[46] K. Liu, T. Qian, L. Tang, J. Wang, H. Yang, J. Ren, Decreased expression of
microRNA let-7i and its association with chemotherapeutic response in human gastric
cancer, World journal of surgical oncology, 10 (2012) 225.
[47] E.B. Zhang, L. Han, D.D. Yin, R. Kong, W. De, J. Chen, c-Myc-induced, long,
noncoding H19 affects cell proliferation and predicts a poor prognosis in patients with
gastric cancer, Medical oncology, 31 (2014) 914.
[48] M. Sun, F.Y. Jin, R. Xia, R. Kong, J.H. Li, T.P. Xu, Y.W. Liu, E.B. Zhang, X.H.
Liu, W. De, Decreased expression of long noncoding RNA GAS5 indicates a poor
prognosis and promotes cell proliferation in gastric cancer, BMC cancer, 14 (2014)
319.
[49] E.B. Zhang, R. Kong, D.D. Yin, L.H. You, M. Sun, L. Han, T.P. Xu, R. Xia, J.S.
Yang, W. De, J. Chen, Long noncoding RNA ANRIL indicates a poor prognosis of
gastric cancer and promotes tumor growth by epigenetically silencing of
miR-99a/miR-449a, Oncotarget, 5 (2014) 2276-2292.
[50] Z.Y. Xu, Q.M. Yu, Y.A. Du, L.T. Yang, R.Z. Dong, L. Huang, P.F. Yu, X.D.
Cheng, Knockdown of long non-coding RNA HOTAIR suppresses tumor invasion
and reverses epithelial-mesenchymal transition in gastric cancer, International journal
of biological sciences, 9 (2013) 587-597.
[51]Y. Okugawa, Y. Toiyama, K. Hur, S. Toden, S. Saigusa, K. Tanaka, Y. Inoue, Y.
Mohri, M. Kusunoki, C.R. Boland, A. Goel, Metastasis-associated long non-coding
RNA drives gastric cancer development and promotes peritoneal metastasis.
Carcinogenesis 35 (2014) 2731-2739.
[52] B. Zhou, X.Y. Jing, J.Q. Wu, H.F. Xi, G.J. Lu, Down-regulation of long
non-coding RNA LET is associated with poor prognosis in gastric cancer.
International journal of clinical and experimental pathology 7 (2014) 8893-8898.
[53] T.P. Xu, M.D. Huang, R. Xia, X.X. Liu, M. Sun, L. Yin, W.M. Chen, L. Han, E.B.
Zhang, R. Kong, W. De, Y.Q. Shu, Decreased expression of the long non-coding RNA
FENDRR is associated with poor prognosis in gastric cancer and FENDRR regulates
gastric cancer cell metastasis by affecting fibronectin1 expression. Journal of
hematology & oncology 7 (2014) 63.
[54] C.Y. Wang, L. Hua, K.H. Yao, J.T. Chen, J.J. Zhang, J.H. Hu, Long non-coding
RNA CCAT2 is up-regulated in gastric cancer and associated with poor prognosis.
International journal of clinical and experimental pathology 8 (2015) 779-785.